Funny that. I was called a down-ramper when I dared to question the exuberance at $0.30+ and now an up-ramper by you at $0.057. You are obviously not a proponent of buying under-valued stocks and selling over-valued stocks.
"This stock is dead" you say. Perhaps. But the company and its prospects anything but. Two more days of EOFY tax credit selling and hopefully an end to recent shareholder pain:
Ann: Imugene onCARlytics Doses First Patient in IV Combination, page-170
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
